Literature DB >> 19128206

Alzheimer's disease, ceramide, visfatin and NAD.

James D Adams1.   

Abstract

This review discusses new mechanisms for the induction of Alzheimer's disease, involving lipid toxicity and adipokines. Ceramide induces oxidative stress and the formation of amyloid beta. Visfatin induces oxidative stress, damages the blood brain barrier and increases the attraction of monocytes, neutrophils and other white blood cells. A new mechanism for visfatin/NAD (nicotinamide adenine dinucleotide)-induced oxidative stress is presented involving redox cycling catalyzed by xanthine dehydrogenase and NADH oxidase. These mechanisms are discussed in terms of the treatment of Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19128206     DOI: 10.2174/187152708787122969

Source DB:  PubMed          Journal:  CNS Neurol Disord Drug Targets        ISSN: 1871-5273            Impact factor:   4.388


  5 in total

1.  Ceramide-mediated insulin resistance and impairment of cognitive-motor functions.

Authors:  Suzanne M de la Monte; Ming Tong; VanAnh Nguyen; Mashiko Setshedi; Lisa Longato; Jack R Wands
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 2.  Obesity as a risk factor for Alzheimer's disease: the role of adipocytokines.

Authors:  Liliana Letra; Isabel Santana; Raquel Seiça
Journal:  Metab Brain Dis       Date:  2014-02-20       Impact factor: 3.584

Review 3.  Insulin resistance and neurodegeneration: roles of obesity, type 2 diabetes mellitus and non-alcoholic steatohepatitis.

Authors:  Suzanne M de la Monte; Lisa Longato; Ming Tong; Jack R Wands
Journal:  Curr Opin Investig Drugs       Date:  2009-10

4.  Visfatin induces oxidative stress in differentiated C2C12 myotubes in an Akt- and MAPK-independent, NFkB-dependent manner.

Authors:  Radu C Oita; Dudley Ferdinando; Steve Wilson; Christopher Bunce; Dawn J Mazzatti
Journal:  Pflugers Arch       Date:  2009-11-08       Impact factor: 3.657

5.  Heteromeles Arbutifolia, a Traditional Treatment for Alzheimer's Disease, Phytochemistry and Safety.

Authors:  Xiaogang Wang; Raphael Dubois; Caitlyn Young; Eric J Lien; James D Adams
Journal:  Medicines (Basel)       Date:  2016-07-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.